Enfortumab vedotin is now available for patients who received prior platinum-containing chemotherapy and a PD-1/L1 inhibitor ...

Significant contributions have been made by technological improvements in radiotherapy, as well as by the introduction of novel chemotherapy agents and dosing schedules. This article will review ...

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming the prognosis for men whose disease has already progressed during or after docetaxel ...

Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find ...

Nerve Freedom is a top-rated supplement for neuropathy & nerve pain relief. Targets inflammation, supports nerve regeneration ...

Introduction Cancer supportive care drugs are designed to alleviate the side effects caused by cancer and its treatments, thereby enhancing the ...

Through the launch of Venetoclax for the treatment of both Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia (CLL ...

The third edition of Introduction to Metadata, first published in 1998, provides an overview of metadata, including its types, roles, and characteristics; a discussion of metadata as it relates to web ...

Negative Breast Cancer Market Insight, Epidemiology and Market Forecast - 2035" report delivers comprehensive insights into triple-negative breast cancer, i ...

The 3-year overall survival rates for each group were 83.1% for the MSD-ASCT group, 85.7% for the auto-HSCT group, and 70.4% for the chemotherapy group. For patients with acute myeloid leukemia ...

An Introduction to Doing Business in Hong Kong 2025-26, the latest publication from China Briefing and Dezan Shira & Associates, is out now and available for download through the Asia Briefing ...

Dr. Deepa Masrani from Mercy Medical Center joins Jenyne to give an introduction to Contrast Mammography.